Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.

Daniel RanchMingwei FeiElisabeth KincadeKim PiburnKelley M K Hitchman Kelsey Klein

Published in: Pediatric transplantation (2023)

Our findings support dd-cfDNA as a useful indicator of graft rejection and response to treatment. Additional studies are needed to determine the role of dd-cfDNA in graft health surveillance.

Keyphrases

public health
healthcare
mental health
case control
combination therapy
replacement therapy